Mechanical phenotype of cancer cells: cell softening and loss of stiffness sensing.
Mechanical phenotype of cancer cells: cell softening and loss of stiffness sensing.
复制标题
DOI:
10.18632/oncotarget.4173
复制
发表时间:
2015-08-28
期刊:
影响因子:
--
通讯作者:
Tang MJ
中科院分区:
文献类型:
--
作者:
Lin HH;Lin HK;Lin IH;Chiou YW;Chen HW;Liu CY;Harn HI;Chiu WT;Wang YK;Shen MR;Tang MJ
The stiffness sensing ability is required to respond to the stiffness of the matrix. Here we determined whether normal cells and cancer cells display distinct mechanical phenotypes. Cancer cells were softer than their normal counterparts, regardless of the type of cancer (breast, bladder, cervix, pancreas, or Ha-RasV12-transformed cells). When cultured on matrices of varying stiffness, low stiffness decreased proliferation in normal cells, while cancer cells and transformed cells lost this response. Thus, cancer cells undergo a change in their mechanical phenotype that includes cell softening and loss of stiffness sensing. Caveolin-1, which is suppressed in many tumor cells and in oncogene-transformed cells, regulates the mechanical phenotype. Caveolin-1-upregulated RhoA activity and Y397FAK phosphorylation directed actin cap formation, which was positively correlated with cell elasticity and stiffness sensing in fibroblasts. Ha-RasV12-induced transformation and changes in the mechanical phenotypes were reversed by re-expression of caveolin-1 and mimicked by the suppression of caveolin-1 in normal fibroblasts. This is the first study to describe this novel role for caveolin-1, linking mechanical phenotype to cell transformation. Furthermore, mechanical characteristics may serve as biomarkers for cell transformation.